CEL-SCI Corp (CVM)
1.74
+0.11
(+6.75%)
USD |
NYAM |
May 06, 16:00
1.74
0.00 (0.00%)
After-Hours: 18:12
CEL-SCI Cash from Investing (Quarterly): -0.0649M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0649M |
| September 30, 2023 | -0.0104M |
| June 30, 2023 | -0.1969M |
| March 31, 2023 | -0.1115M |
| December 31, 2022 | -0.0536M |
| September 30, 2022 | -0.0161M |
| June 30, 2022 | -0.071M |
| March 31, 2022 | -0.5338M |
| December 31, 2021 | 6.112M |
| September 30, 2021 | 4.590M |
| June 30, 2021 | -2.000M |
| March 31, 2021 | -14.62M |
| December 31, 2020 | -3.150M |
| September 30, 2020 | -1.125M |
| June 30, 2020 | -0.8035M |
| March 31, 2020 | -0.6571M |
| December 31, 2019 | -0.1097M |
| September 30, 2019 | -0.049M |
| June 30, 2019 | -0.0582M |
| March 31, 2019 | -0.1563M |
| December 31, 2018 | -0.0723M |
| September 30, 2018 | -0.0547M |
| June 30, 2018 | -0.0023M |
| March 31, 2018 | -0.0002M |
| December 31, 2017 | -0.001M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0065M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.0105M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.0022M |
| June 30, 2016 | -0.0148M |
| March 31, 2016 | -0.0068M |
| December 31, 2015 | -0.0148M |
| September 30, 2015 | -0.0275M |
| June 30, 2015 | -0.0076M |
| March 31, 2015 | -0.0414M |
| December 31, 2014 | -0.0171M |
| September 30, 2014 | -0.0387M |
| June 30, 2014 | -0.0476M |
| March 31, 2014 | -0.044M |
| December 31, 2013 | -0.0086M |
| September 30, 2013 | -0.0149M |
| June 30, 2013 | -0.0309M |
| March 31, 2013 | -0.0708M |
| December 31, 2012 | -0.0162M |
| September 30, 2012 | -0.0114M |
| June 30, 2012 | -0.0409M |
| March 31, 2012 | -0.0645M |
| December 31, 2011 | -0.0168M |
| September 30, 2011 | -0.1186M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-14.62M
Minimum
Mar 2021
6.112M
Maximum
Dec 2021
-0.6807M
Average
-0.1097M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| Synlogic Inc | -14.63M |
| BioXcel Therapeutics Inc | 0.00 |
| IGM Biosciences Inc | -14.69M |
| Intelligent Bio Solutions Inc | -0.0567M |
| Syra Health Corp | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.888M |
| Cash from Financing (Quarterly) | 4.048M |
| Free Cash Flow | -23.45M |
| Free Cash Flow Per Share (Quarterly) | -0.1022 |
| Free Cash Flow Yield | -29.47% |